Hamilton Healthcare YIELD MAXIMIZER™ ETF
Maximize Income from Healthcare Leaders
HIGHLIGHTS
Yield of 11.98%*An estimate of the annualized yield an investor would receive if the most recent distribution remained unchanged for the next 12 months, stated as a percentage of the price per unit on December 31, 2025. The yield calculation excludes any additional year end distributions and does not include reinvested distributions. with monthly distributions
Diversification beyond single stocks with exposure to the largest healthcare companies
Flexible coverage ratio adjusted to achieve target yield and preserve upside
Active covered call strategy managed by options team with 50+ years of experience, led by Nick Piquard
A GOOD FIT FOR INVESTORS WHO WANT
Higher tax-efficient monthly income
Modest long-term growth potential
Unhedged exposure to the largest healthcare companies in the U.S.
Reduced volatility from options strategy
INVESTMENT OBJECTIVE
LMAX is designed for attractive monthly income, while providing exposure to an equal-weight portfolio of primarily U.S. large-cap healthcare companies. To reduce volatility and augment dividend income, LMAX will employ an active covered call strategy.
LMAX does not use leverage.
Performance
- TICKER LMAX
- NAV $14.27
- 1 DAY CHANGE +$0.05
-
YIELD % *
Current annualized yield.
11.98 - ASSETS $161.9M
Total Returns (incl. Dividends)
- ticker 0.0%
- 1 month -2.6%
- 3 months 7.5%
- 6 months 11.8%
- ytd 6.8%
- 1 year 6.8%
- inception* 6.1%
- as of date 202500.0%
Hamilton YIELD MAXIMIZER™ ETFs
- Overview
- Distributions
- Documents
| ticker | name | weight |
| LLY | Eli Lilly & Co | 5.8% |
| MRK | Merck & Co Inc | 5.8% |
| BMY | Bristol-Myers Squibb Co | 5.7% |
| JNJ | Johnson & Johnson | 5.5% |
| ISRG | Intuitive Surgical Inc | 5.5% |
| VRTX | Vertex Pharmaceuticals Inc | 5.5% |
| DHR | Danaher Corp | 5.5% |
| TMO | Thermo Fisher Scientific Inc | 5.4% |
| AMGN | Amgen Inc | 5.3% |
| MCK | McKesson Corp | 5.1% |
| GILD | Gilead Sciences Inc | 5.1% |
| MDT | Medtronic PLC | 4.8% |
| ABBV | AbbVie Inc | 4.7% |
| PFE | Pfizer Inc | 4.7% |
| BSX | Boston Scientific Corp | 4.6% |
| CVS | CVS Health Corp | 4.5% |
| UNH | UnitedHealth Group Inc | 4.5% |
| ABT | Abbott Laboratories | 4.4% |
| SYK | Stryker Corp | 4.4% |
| CI | Cigna Group/The | 4.4% |
| Written Call Options | -0.4% | |
| Cash and Other Assets/Liabilities | -0.8% |
| Ticker | LMAX |
| Exchange | Toronto Stock Exchange (TSX) |
| CUSIP | 406919100 |
| Inception Date | February 6, 2024 |
| Investment Style | Healthcare, Covered Call |
| Assets | $161.9M CAD* |
| Current Annualized Yield | 11.98%* |
| Distributions | Monthly |
| Currency Hedging | CAD-unhedged |
| Rebalancing | Semi-annual |
| Management Fee | 0.65% |
| Risk Rating | Medium |
| Auditor | KPMG LLP |
| Legal Entity Identifier | 254900Q4N3BE15RJTE17 |
| Ex-Dividend Date | Pay Date | Frequency | Amount |
|---|---|---|---|
| 2025-12-31 | 2026-01-08 | Monthly | $0.1420 |
| 2025-11-28 | 2025-12-05 | Monthly | $0.1430 |
| 2025-10-31 | 2025-11-07 | Monthly | $0.1420 |
| 2025-09-29 | 2025-10-07 | Monthly | $0.1420 |
| 2025-08-29 | 2025-09-08 | Monthly | $0.1450 |
| 2025-07-31 | 2025-08-08 | Monthly | $0.1450 |
| 2025-06-30 | 2025-07-08 | Monthly | $0.1500 |
| 2025-05-30 | 2025-06-06 | Monthly | $0.1510 |
| 2025-04-30 | 2025-05-07 | Monthly | $0.1540 |
| 2025-03-31 | 2025-04-07 | Monthly | $0.1570 |
| 2025-02-28 | 2025-03-07 | Monthly | $0.1560 |
| 2025-01-31 | 2025-02-07 | Monthly | $0.1560 |
| 2024-12-31 | 2025-01-08 | Monthly | $0.1570 |
| 2024-11-29 | 2024-12-06 | Monthly | $0.1560 |
| 2024-10-31 | 2024-11-07 | Monthly | $0.1550 |
| 2024-09-27 | 2024-10-07 | Monthly | $0.1570 |
| 2024-08-30 | 2024-09-09 | Monthly | $0.1570 |
| 2024-07-31 | 2024-08-08 | Monthly | $0.1580 |
| 2024-06-28 | 2024-07-08 | Monthly | $0.1580 |
| 2024-05-31 | 2024-06-07 | Monthly | $0.1600 |
| 2024-04-29 | 2024-05-07 | Monthly | $0.1550 |
| 2024-03-27 | 2024-04-05 | Monthly | $0.1475 |
| 2024-02-28 | 2024-03-07 | Monthly | $0.1466 |
You can view public filings for the Hamilton Healthcare YIELD MAXIMIZER™ ETF on SEDAR+.
Press Releases
View the latest LMAX Press Releases
Fact Sheet
LMAX Fact Sheet (2025-11-28) English Français
ETF Facts
LMAX ETF Facts (2025-01-09) English Français
Prospectus
LMAX Prospectus (2025-06-02) English Français
Financial Statements & MRFP
Annual Report (2024-12-31) English Français
Interim Report (2025-06-30) English Français
Latest Portfolio Summary
Q3 2025 Portfolio Summary (2025-09-30) Download
Proxy Voting
Proxy Voting Report (2024-07 to 2025-06) Download
Independent Review Committee
2024 Annual Report to Securityholders (2025-03-11) Download